323 related articles for article (PubMed ID: 33248113)
1. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
[TBL] [Abstract][Full Text] [Related]
2. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
[TBL] [Abstract][Full Text] [Related]
3. Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome.
Hamilton MJ; Zhao M; Giannetti MP; Weller E; Hufdhi R; Novak P; Mendoza-Alvarez LB; Hornick J; Lyons JJ; Glover SC; Castells MC; Pozdnyakova O
Am J Surg Pathol; 2021 Jul; 45(7):997-1004. PubMed ID: 33481382
[TBL] [Abstract][Full Text] [Related]
4. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
[TBL] [Abstract][Full Text] [Related]
5. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM
J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122
[TBL] [Abstract][Full Text] [Related]
6. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
Luskin KT; White AA; Lyons JJ
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
[TBL] [Abstract][Full Text] [Related]
7. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
[TBL] [Abstract][Full Text] [Related]
8. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.
Lyons JJ; Chovanec J; O'Connell MP; Liu Y; Šelb J; Zanotti R; Bai Y; Kim J; Le QT; DiMaggio T; Schwartz LB; Komarow HD; Rijavec M; Carter MC; Milner JD; Bonadonna P; Metcalfe DD; Korošec P
J Allergy Clin Immunol; 2021 Feb; 147(2):622-632. PubMed ID: 32717252
[TBL] [Abstract][Full Text] [Related]
9. Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.
Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C
Int Arch Allergy Immunol; 2019; 180(1):44-51. PubMed ID: 31256161
[TBL] [Abstract][Full Text] [Related]
10. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
[TBL] [Abstract][Full Text] [Related]
12. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
Wu R; Lyons JJ
Curr Allergy Asthma Rep; 2021 May; 21(5):33. PubMed ID: 33970354
[TBL] [Abstract][Full Text] [Related]
13. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
[TBL] [Abstract][Full Text] [Related]
14. [Tryptase: A practical guide for the physician].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042
[TBL] [Abstract][Full Text] [Related]
15. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
[TBL] [Abstract][Full Text] [Related]
18. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
19. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
20. Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy.
Novak P; Giannetti MP; Weller E; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2022 Mar; 128(3):299-306.e1. PubMed ID: 34648976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
